Company signals
Netskope
2 signals in the current window, with MitchelLake's leadership read on each.
Market context: This lands while the Talent Market Index reads 110 (Hot) — up 11.7 versus the prior month — and EMEA signal share is rising (+1.7pts).
Netskope: 2 signals in the last 90 days; 0.1% of MitchelLake's EMEA signal flow; 2 tracked across 45 days.
Signals at Netskope
Product Launch
AmericasNetskope released its 2026 Cloud and Threat Report, revealing that nearly 50% of enterprise generative AI users access unsanctioned AI tools through personal accounts, with an average organization reporting 223 AI policy violations monthly. The report identifies shadow AI as adding $670,000 to average breach costs.
Leadership read: Product momentum tends to widen the sector product and commercial leadership bench strength.
curated · 2026-06-19 · context →
Product Launch
EMEANetskope launched AgentSkope with agentic AI capabilities for DLP analysis and insider threat triage, revolutionizing their security platform
Leadership read: Product momentum tends to widen the sector product and commercial leadership bench strength.
curated · 2026-05-05 · context →
More signals across EMEA
Product Launch · EMEA
Cleo →London-based Cleo surpassed $400m ARR just months after hitting $300m ARR, signaling acceleration in product adoption and market expansion toward the $500m ARR milestone.
Product Launch · EMEA
Form3 →Form3 demonstrating active/active/active multi-cloud payments architecture across AWS, GCP, and Azure with rigorous disaster-recovery testing, signaling maturity of production payment infrastructure.
Product Launch · EMEA
Cockroach Labs →Cockroach Labs launching RoachFest London 2026 to promote CockroachDB as enterprise solution for AI workloads and agentic systems; announcing roadmap including bring-your-own-cloud, AI-powered migration tooling, and price-performance improvements.
Product Launch · EMEA
Bristol Myers Squibb →Bristol Myers Squibb reported positive Phase III clinical trial results for mezigdomide (multiple myeloma) and early-stage CAR T-cell therapy arlocabtagene autoleucel with strong response rates and manageable safety profiles, presented at European Hematology Association Congress 2026.
Product Launch · EMEA
Adecco →Adecco announced milestone of over one million AI-powered candidate interactions, scaling human-centred AI recruitment across 10 countries with 50% reduction in time-to-deliver and improved fill rates
Product Launch · EMEA
Qualitest →Qualitest rebranded as QualityAI and shifted strategic focus toward AI assurance services
Intelligence powered by Autonodal ↗